Overall Status

Completed (16)

Unknown status (4)

Active, not recruiting (3)

No longer available (1)

Recruiting (1)

Terminated (1)

Withdrawn (1)

Phase

phase 2 (10)

phase 2/phase 3 (3)

phase 1 (2)

phase 3 (2)

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto (13)

Bristol-Myers Squibb (7)

Novartis Pharmaceuticals (2)

Ariad Pharmaceuticals (1)

Gamida Cell -Teva Joint Venture Ltd. (1)

Gruppo Italiano Trapianto di Midollo Osseo (1)

IRCCS San Raffaele (1)

Pfizer (1)

Collaborator

CML Advocates Network (1)

European Leukemia Net (1)

Fondazione Adecco per le Pari Opportunita (1)

ICON Clinical Research (1)

Wyeth is now a wholly owned subsidiary of Pfizer (1)

Study Documents

Intervention Type

drug (19)

other (4)

behavioral (2)

Funder Type

Other (16)

Industry (11)

Study Type

Interventional (17)

Observational (9)

Expanded Access (1)

Chronic Myeloid Leukemia

Showing NaN - NaN of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloid Leukemia, Blast Crisis Trial in Worldwide (Dasatinib)

Completed

Has Results

Chronic Myeloid Leukemia
Blast Crisis

Dasatinib

Birmingham, Alabama
+61 more

Aug 3, 2010

Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Italy (Treosulfan IV)

Unknown status

Leukemia
+6 more

Treosulfan IV

San Giovanni Rotondo, Foggia, Italy
+11 more

Aug 10, 2009